IL17A and metabolic dysfunction-associated steatotic liver disease: This latter IL-17-mediated effect together with the known role of IL-6, in synergy with TGF-β in enhancing the differentiation and proliferation of Th17 (149), constitute a positive feedback loop between hepatocytes and Th17 cells in the context of MASLD.